Category: Industrial members

The Janssen campus in Belgium (or Janssen Pharmaceutica) is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. A unique fusion of expertise, capabilities and partnerships in R&D, manufacturing and new product launch. Together, they are creating a future where disease is a thing of the past.

As an innovative campus, they focus on important fields of research such as neuroscience, oncology, immunology, infectious diseases, cardiovascular and metabolism and pulmonary hypertension. Fields in which the unmet medical need is high and much is to be done and to achieved.

Janssen in Belgium has been focusing on research and development for more than 60 years. The campus in Belgium has been instrumental in the discovery and development of a new generation of tuberculosis, HIV/AIDS, cancer, infectious diseases and neurological drugs. It was here in Beerse that the first FDA-approved tuberculosis drug in 40 years was discovered and developed.

From early research and development, through supply chain to patient access – their people are making an important contribution to the health of many.

OTHER INDUSTRIAL MEMBERS

Cognizant engineers modern businesses. They help their clients modernize technology, reimagine processes and transform experiences so they can stay ahead in the fast-changing world.

Cognizant uses expertise that’s been proven and tested around the globe to help their customers get ahead of challenges, sense opportunities sooner and outpace change.

They develop game-changing digital solutions in many different fields of expertise:

• Digital Engineering
• Intelligent Process Automation
• Industry & Platform Solutions
• Internet of Things
• Artificial Intelligence
• Cloud
• Data
• Life Sciences
• Healthcare
• Manufacturing
• Technology
• …

OTHER INDUSTRIAL MEMBERS

AM-Team was founded in 2017 by Dr. Wim Audenaert, Dr. Usman Rehman, and Prof. Ingmar Nopens, all having MSc and PhD degrees in either chemical or environmental engineering. AM-Team is a spinoff company of Ghent University with over a decade of expertise in process modelling and simulations.

Customers from all over the globe rely on their leading-edge simulation services and digital tools. They keep on developing tailored digital solutions to match the needs of their customers in the process industry.

They do this by: 

• Developing new process models and methodologies to maximise customer experience and cater the industry needs
• Sharing their expertise at high-level international events and publishing new findings in peer-reviewed scientific papers, often together with customers
• Investing in new hardware and software to maximise simulation speed and accuracy

Thanks to their large team of dedicated simulation engineers, they can handle large projects in a short timeframe. 

OTHER INDUSTRIAL MEMBERS

Secoya Technologies is a global provider of services and equipment in particle engineering for the (bio)-pharmaceutical industry. Secoya’s experts have been developing innovative production technologies and equipment by a smart use of micro-structured elements, enabling a faster, precise and secure development and production process.

Their ranges of robust intensified reactors guarantee a stable and reliable production process – at different scale – of high quality (bio-)pharmaceutical products. Their core principle is applied to following technologies and in-house expertise service:

• Crystallization (small molecules, API, excipients…)
• Emulsification / Encapsulation (simple and double emulsion for encapsulation of biomolecules, API…)
• Pervaporation
• Process intensification

The integration of their unique, robust and versatile technologies in their equipment, combined with their unique know-how, allows them to guide their partners with mastering every aspect of the manufacturing process, from laboratory scale to commercial production scale the size of the particles generated and their size distribution as well as to increase the efficiency, productivity and flexibility. Whether it is the development of new products or the improvement of existing products, Secoya’s technologies provide many key benefits:

• Unmatched product quality and secure production
• Implementation of Quality-by-Design
• Reduction of investment cost and risk for the process development
• Reduction of cost of goods sold
• Inherent compatibility with continuous manufacturing
• Manufacturing of new possible molecules

OTHER INDUSTRIAL MEMBERS

RheaVita sells single vial (for R&D), non-GMP multi-vial (for scale-up and stability studies), and full GMP continuous freeze-drying systems.

Next to our engineered solutions we also offer freeze-drying related CDMO services. The freeze-drying of biopharmaceuticals, LNP-based formulations, ATMPs, and other small and large molecules, requires proper formulation and process optimization of the drug substance. Designing the optimal formulation based on the drug substance properties and characteristics is crucial. Furthermore, by applying a model-based strategy, RheaVita provides the opportunity to efficiently design and optimize your freeze-drying process in an extremely fast way with limited product consumption. 

Our manufacturing approach avoids scale-up issues, reduces cycle times, allows fast product development, reduces time-to-patient, lowers production costs, makes use of smaller manufacturing installations, requires less clean room space, provides improved quality assurance thanks to PAT (100% inspection with inherent potential for real-time-release) and leads to improved and uniform product quality and process uniformity.

RheaVita has also set up an academy to share knowledge on freeze-drying where our customers receive a fundamental insight into freeze-drying and analysis of the results and experience the benefits of continuous manufacturing technology.

OTHER INDUSTRIAL MEMBERS